Stephen Gordon - 01 May 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: Chief Financial Officer
Signature: By: /s/ Stephen Gordon
Issuer symbol: TMDX
Transactions as of: 01 May 2023
Net transactions value: -$314,550
Form type: 4
Filing time: 02 May 2023, 18:31:56 UTC
Previous filing: 02 Mar 2023
Next filing: 04 Oct 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Options Exercise	$80,700	+5,000	+27%	$16.14^*	23,789	01 May 2023	Direct	F1
transaction	TMDX	Common Stock	Sale	$395,250	-5,000	-21%	$79.05	18,789	01 May 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TMDX	Stock Option (Right to Buy)	Options Exercise	$0	-5,000	-32%	$0.000000	10,728	01 May 2023	Common Stock	5,000	$16.14	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022.
F2	Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F3	The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024.